Abstract:Hypoxia is a common feature of most solid tumors, which promotes the proliferation, invasion, metastasis, and therapeutic resistance of tumors. Researchers have been developing advanced strategies and nanoplatforms to modulate tumor hypoxia to enhance therapeutic effects. A timely review of this rapidly developing research topic is therefore highly desirable. For this purpose, this review first introduces the impact of hypoxia on tumor development and therapeutic resistance in detail. Current developments in the construction of various nanoplatforms to enhance tumor treatment in response to hypoxia are also systematically summarized, including hypoxia-overcoming, hypoxia-exploiting, and hypoxia-disregarding strategies. We provide a detailed discussion of the rationale and research progress of these strategies. Through a review of current trends, it is hoped that this comprehensive overview can provide new prospects for clinical application in tumor treatment. STATEMENT OF SIGNIFICANCE: As a common feature of most solid tumors, hypoxia significantly promotes tumor progression. Advanced nanoplatforms have been developed to modulate tumor hypoxia to enhanced therapeutic effects. In this review, we first introduce the impact of hypoxia on tumor progression. Current developments in the construction of various nanoplatforms to enhance tumor treatment in response to hypoxia are systematically summarized, including hypoxia-overcoming, hypoxia-exploiting, and hypoxia-disregarding strategies. We discuss the rationale and research progress of the above strategies in detail, and finally introduce future challenges for treatment of hypoxic tumors. By reviewing the current trends, this comprehensive overview can provide new prospects for clinical translatable tumor therapy.

Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies

The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions

Tumor hypoxia: From basic knowledge to therapeutic implications

Recent Advances in the Study of Bioreductive Drugs Targeted Tumor Hypoxia

Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications

Hypoxia Signaling in Cancer: Implications for Therapeutic Interventions

Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies

Hypoxia: Intriguing Feature in Cancer Cell Biology

Current Advances in Modulating Tumor Hypoxia for Enhanced Therapeutic Efficacy.

Tumor hypoxia and heterogeneity: Challenges and opportunities for the future

Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy

Hypoxia-activated nanomedicines for effective cancer therapy

Autonomous Glucose Metabolic Reprogramming of Tumour Cells under Hypoxia: Opportunities for Targeted Therapy

Targeting Tumor Hypoxia with Nanoparticle-Based Therapies: Challenges, Opportunities, and Clinical Implications

Hypoxic tumor microenvironment: Opportunities to develop targeted therapies

Hypoxia-regulated gene network in drug resistance and cancer progression

Hypoxia signaling: Challenges and opportunities for cancer therapy

Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation

How to overcome (and exploit) tumor hypoxia for targeted gene therapy

Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment

Role of hypoxia in cancer therapy by regulating the tumor microenvironment